| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
HIGH-RISK PREGNANCY SERIES: AN EXPERT'S VIEW |
From the Department of Obstetrics and Gynecology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Address reprint requests to: Steven G. Gabbe, MD, Vanderbilt University Medical Center, D-3300 Medical Center North, Nashville, TN 37232-2104; E-mail: steven.gabbe{at}vanderbilt.edu.
Diabetes mellitus complicates 3–5% of all pregnancies and is a major cause of perinatal morbidity and mortality, as well as maternal morbidity. The availability of a variety of new insulins, the insulin pump, and self-monitoring of blood glucose have revolutionized the care of the pregnancy complicated by diabetes mellitus. However, challenges remain in caring for the pregnant patient with pregestational diabetes. Relatively few women receive preconceptional counseling, and major fetal malformations as a result of poor glucose control before and during the early weeks of gestation have emerged as the major cause of perinatal mortality. When the patient has diabetic vasculopathy, the obstetrician, maternal–fetal specialist, and/or endocrinologist and other members of the health care team must perform a challenging balancing act that promotes fetal health while minimizing maternal risk. As obesity increases in this country and our population becomes more diversified, the rate of gestational diabetes mellitus (GDM) will rise. Although there is controversy regarding which diagnostic standards to use for GDM, there is agreement that excellent blood glucose control, with diet and, when necessary, insulin will result in improved perinatal outcome. Finally, the goal of our educational programs should be not only to improve pregnancy outcome but also to promote healthy lifestyle changes for the mother that will last long after delivery.
This article has been cited by other articles:
|
|
 |
|
  J. L. Kitzmiller, J. M. Block, F. M. Brown, P. M. Catalano, D. L. Conway, D. R. Coustan, E. P. Gunderson, W. H. Herman, L. D. Hoffman, M. Inturrisi, et al. Managing Preexisting Diabetes for Pregnancy: Summary of evidence and consensus recommendations for care Diabetes Care, May 1, 2008; 31(5): 1060 - 1079. [Full Text] [PDF]
|
|
|
|
|
|
G. L. Nielsen, C. Dethlefsen, H. T. Sorensen, J. F. Pedersen, and L. Molsted-Pedersen Cognitive Function and Army Rejection Rate in Young Adult Male Offspring of Women With Diabetes: A Danish population-based cohort study Diabetes Care, November 1, 2007; 30(11): 2827 - 2831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Damm, E. R. Mathiesen, K. R. Petersen, and S. Kjos Contraception After Gestational Diabetes Diabetes Care, July 1, 2007; 30(Supplement_2): S236 - S241. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Langer Oral Antidiabetic Drugs in Pregnancy: The Other Alternative Diabetes Spectr, April 1, 2007; 20(2): 101 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M EZIMOKHAI, A. JOSEPH, and P BRADLEY-WATSON Audit of Pregnancies Complicated by Diabetes from One Center Five Years Apart with Selective versus Universal Screening Ann. N.Y. Acad. Sci., November 1, 2006; 1084(1): 132 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. K. Nicholson, H. E. Fox, L. A. Cooper, D. Strobino, F. Witter, and N. R. Powe Maternal Race, Procedures, and Infant Birth Weight in Type 2 and Gestational Diabetes. Obstet. Gynecol., September 1, 2006; 108(3): 626 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mosca, R. Paleari, M. G. Dalfra, G. Di Cianni, I. Cuccuru, G. Pellegrini, L. Malloggi, M. Bonomo, S. Granata, F. Ceriotti, et al. Reference Intervals for Hemoglobin A1c in Pregnant Women: Data from an Italian Multicenter Study Clin. Chem., June 1, 2006; 52(6): 1138 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Debieve, L. Hinck, J.-M. Biard, P. Bernard, and C. Hubinont Activin receptor expression and induction of apoptosis in rat blastocysts in vitro Hum. Reprod., March 1, 2006; 21(3): 618 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Nicholson, L. A. Fleisher, H. E. Fox, and N. R. Powe Screening for Gestational Diabetes Mellitus: A decision and cost-effectiveness analysis of four screening strategies Diabetes Care, June 1, 2005; 28(6): 1482 - 1484. [Full Text] [PDF]
|
|
|
|
 |
|
 I. B. Hirsch Insulin Analogues N. Engl. J. Med., January 13, 2005; 352(2): 174 - 183. [Full Text] [PDF]
|
|
|
|
|
|
S. G. Gabbe, R. P. Gregory, M. L. Power, S. B. Williams, and J. Schulkin Management of Diabetes Mellitus by Obstetrician-Gynecologists Obstet. Gynecol., June 1, 2004; 103(6): 1229 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Jelsema Management of Diabetes Mellitus Complicating Pregnancy Obstet. Gynecol., January 1, 2003; 103(3): 586 - 586. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
